Navigation Links
PharmaNet Shares Expertise in Drug Development Outsourcing at the 2011 Partnerships in Clinical Trials Conference
Date:3/21/2011

PRINCETON, N.J., March 21, 2011 /PRNewswire/ -- PharmaNet Development Group, Inc., a leading provider of drug development services to the pharmaceutical, biotechnology, generic drug and medical device industries, announces its participation at the 19th Annual Partnerships in Clinical Trials Conference in Phoenix, Arizona from March 30 to April 1. PharmaNet and industry experts will discuss pertinent industry topics, including:

Thursday March 31

Impact of Reform on Biosimilar Drug Development

Dalvir Gill, Ph.D., President, Late Stage Development, PharmaNet and Greg Skalicky, Senior Vice President, Worldwide Business Development, PharmaNet

Proactive GCP Compliance and Quality Management Systems

Jeffrey P. McMullen, CEO, PharmaNet and John W. Hubbard, Ph.D., FCP, Senior Vice President Worldwide Head, Development Operations, Pfizer

Assess the Impact of Industry Consolidation on Change Management and Your Outsourcing Operational Model

Marisa Bower, Senior Director, Business Development, PharmaNet

Outsourcing Phase IV Observational Studies: A Different Animal?

Jeffrey Trotter, Executive Vice President, Phase IV Development, PharmaNet

Friday April 1

Challenges and Opportunities in the Global Arena in Pediatric Drug Development

Philippa Smit-Marshall, MBChB, FFPM, FICR, Vice President and General Manager of Pediatrics & Medical Sciences, PharmaNet; and Diane Hoffman, Associate Director, Clinical Research Pediatric Group, Johnson & Johnson

Conference attendees can learn more about PharmaNet's capabilities by visiting booth 901 in the exhibition hall where an international team of representatives will be available to discuss PharmaNet's expertise in helping clients reach their goal of delivering safe and effective therapeutics to patients.

About PharmaNet

PharmaNet, a recognized leader of global drug development services to the pharmaceutical, biotechnology, generic drug, and medical device industries, provides comprehensive capabilities in Phase I-IV clinical development, bioanalytical and bioequivalence services, regulatory, staffing, and therapeutic solutions. For the applied knowledge and intelligent solutions needed to accelerate drug development programs of all sizes around the world, PharmaNet works for you. For more information, please visit www.PharmaNet.com.

Contact: Anne-Marie Hess
Phone:   (609) 951-6842
E-mail:   ahess@pharmanet.com


'/>"/>
SOURCE PharmaNet Development Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dr. Jeffrey Freitag Appointed Chief Medical Officer of PharmaNet
2. PharmaNet and Anapharm Europe Formally End Joint Venture
3. Catherine Derasp Joins PharmaNet as Vice President, Clinical Operations
4. PharmaNets Technology Investments Translate to Enhanced Client Service in Its Phase I Clinics
5. PharmaNet Launches New Brand Identity at Upcoming Industry Conferences
6. PharmaNet Development Group Announces Observational Research Survey
7. Steven Leventer Joins PharmaNet Development Group as Vice President, Clinical Research Neuroscience
8. PharmaNet Development Group Symposia Crossing the Bridge from Preclinical to Clinical Studies to be Held February 2010 in Basel, Dusseldorf and Vienna
9. Jeffrey Trotter Joins Pharmanet Development Group as Executive Vice President, Phase IV Development
10. PharmaNet Development Group Management Participates in the 8th Annual Partnerships in Clinical Trials Conference in Rotterdam
11. Azopharma and PharmaNet Development Group Enter Preclinical Strategic Alliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... to their offering. The ... commercial environment for MedImmune to enter. The US ageing population ... to drive considerable growth for effective anti-influenza medications. The introduction ... considerably, but development is still in its infancy. ...
Breaking Medicine Technology:
(Date:6/27/2016)... California (PRWEB) , ... June 27, 2016 , ... "FCPX ... fully customizable inside of Final Cut Pro X," said Christina Austin - CEO of ... unique style. Final Cut Pro X users can now reveal the media ...
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... have been diagnosed with endometriosis. These women need a treatment plan to not ... comprehensive approach that can help for preservation of fertility and ultimately achieving a ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/24/2016)... Los Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... plastic surgery procedures that most people are unfamiliar with. The article goes on to ... known procedures, but also many of these less common operations such as calf and ...
Breaking Medicine News(10 mins):